Challenges of Fundraising in a Competitive Market: The unique hurdles that biotech and life sciences startups face, particularly in securing funding for innovative but early-stage technologies. Highlight how Brixton Biosciences successfully navigated these challenges, raising $50M to date.
Building Investor Confidence in Novel Therapies: Emphasize the importance of data-driven results and a strong founding team. How Brixton has leveraged its deep scientific rigor and the credibility of being a spin-out from Massachusetts General Brigham to instill confidence in investors.
Balancing Innovation with Scalability: Address the need to present not just groundbreaking technology, but also a clear pathway to market.
